Related Funds
Funds with similar focus
Fund Name | Location |
Ally Capital | China, Shanghai |
BAGi | Catalonia, Girona, Spain |
Baixing.com | China, Shanghai |
Cherry Tree Investments | Minnesota, Minnetonka, United States |
Groupe Prenant | France, Ile-de-France, Vitry-sur-seine |
Itochu TC Construction Machinery | Japan, Tokyo |
Pictet Private Equity Investors S.A. | Geneva, Geneve, Switzerland |
Superior Industries International, Inc. | Michigan, Southfield, United States |
TRUMPF Venture | Baden-Wurttemberg, Ditzingen, Germany |
Zero Mile Warehousing | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
MiAlgae | $19M | 18 Sep 2024 | City of Edinburgh, Scotland, United Kingdom | ||
Solasta Bio | $14M | 11 Sep 2024 | Glasgow City, Glasgow, United Kingdom | ||
Metacarpal | $1M | 27 Aug 2024 | Edinburgh, Scotland, United Kingdom | ||
Nami Surgical | $3M | 08 May 2024 | Glasgow City, Glasgow, United Kingdom | ||
Carcinotech | $5M | 29 Jan 2024 | - | ||
Microplate Dx | $3M | 11 Sep 2023 | Glasgow City, Glasgow, United Kingdom | ||
Solasta Bio | $5M | 27 Mar 2023 | Glasgow City, Glasgow, United Kingdom | ||
Dxcover | $10M | 01 Feb 2023 | - | ||
MiAlgae | $3M | 17 Aug 2022 | City of Edinburgh, Scotland, United Kingdom |
– EnteroBiotix is a biopharmaceutical company based in Glasgow, Scotland.
– The company raised $21m in Series A funding.
– The round was led by Thairm Bio with participation from Kineticos Ventures, Scottish Enterprise and SIS Ventures.
– The new investment will be used to advance the company’s microbiome drug pipeline and product development and manufacturing capabilities and grow its headcount to around 50.
– Solasta Bio from Glasgow specializes in the next generation of green insecticides.
– The company raised £1.3m in seed funding.
– Backers included The Yield Lab Europe, SIS Ventures, members of Cambridge Agritech and UKI2S.
– The company intends to use the funds for ongoing development of its nature-inspired pesticides.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
MiAlgae | $19M | 18 Sep 2024 | City of Edinburgh, Scotland, United Kingdom | ||
Solasta Bio | $14M | 11 Sep 2024 | Glasgow City, Glasgow, United Kingdom | ||
Metacarpal | $1M | 27 Aug 2024 | Edinburgh, Scotland, United Kingdom | ||
Nami Surgical | $3M | 08 May 2024 | Glasgow City, Glasgow, United Kingdom | ||
Carcinotech | $5M | 29 Jan 2024 | - | ||
Microplate Dx | $3M | 11 Sep 2023 | Glasgow City, Glasgow, United Kingdom | ||
Solasta Bio | $5M | 27 Mar 2023 | Glasgow City, Glasgow, United Kingdom | ||
Dxcover | $10M | 01 Feb 2023 | - | ||
MiAlgae | $3M | 17 Aug 2022 | City of Edinburgh, Scotland, United Kingdom |